ENVB
NASDAQ · Pharmaceuticals
Enveric Biosciences Inc
$1.42
+0.02 (+1.71%)
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+595.9% upside
Low Target
$5.56
Average Target
$9.91
High Target
$13.09
Current Price
$1.42
Current
$1.42
$1.42
Target
$9.91
$9.91
$5.56
$9.91 avg
$13.09
Scenario Analysis
Bear Case
$5.56
290.4%
Low target
Base Case
$9.91
+595.9%
Avg target
Bull Case
$13.09
+819.2%
High target
Risk/Reward
2.8x
Favorable
Price in Context
52-Week High
$13.25
-89.3% from high
52-Week Low
$1.17
+21.7% from low
Target vs 52W High
$9.91
-25.2% vs high
Next Earnings Report
Nov 12, 2026
4d
until earnings
Earnings in 4 days. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals